💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Agios Pharmaceuticals, Inc. (AGIO)
« Back to company indexAGIO Chatter Timeline
Stock Ticker for AGIO
Most Active Tweeters for AGIO
| User | Tweets |
|---|---|
| @FlashAlert_me | 7 |
| @MarcJacksonLA | 6 |
| @InsiderAlerts4U | 5 |
| @Tickeron | 4 |
| @mediasentiment | 4 |
Recent Tweets for AGIO
 |
@newton93420295 Entries & exits Daily! Discord link below? https://t.co/nanIHuZbAL $AGIO May 28th 2022, 7:05pm |
 |
@mediasentiment $AGIO new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 66 May 26th 2022, 7:05am |
 |
@inoritrade $AGIO "Waiting for BUY signal on AGIO ? Register for 7-Day Trial Access at https://t.co/WBARPaK0Cc " https://t.co/lBTUycPKLl May 25th 2022, 11:05pm |
 |
@InsiderAlerts4U $AGIO: New Insider Filing on AGIOS PHARMACEUTICALS, INC.'s Director JOHN MARAGANORE: https://t.co/zZzCsNdsnB May 24th 2022, 9:05pm |
|
@InsiderAlerts4U $AGIO: New Insider Filing on AGIOS PHARMACEUTICALS, INC.'s Director PAUL J CLANCY: https://t.co/8V9B9dr78m May 24th 2022, 8:05pm |
 |
@Tickeron $AGIO in +0.95% Uptrend, advancing for three consecutive days on May 17, 2022. View odds for this and other indicat… https://t.co/vtn7cNhj6N May 24th 2022, 8:05pm |
|
@InsiderAlerts4U $AGIO: New Insider Filing on AGIOS PHARMACEUTICALS, INC.'s Director MAYKIN HO: https://t.co/sR4KfC749p May 24th 2022, 8:05pm |
|
@InsiderAlerts4U $AGIO: New Insider Filing on AGIOS PHARMACEUTICALS, INC.'s Director DAVID P SCHENKEIN: https://t.co/qOa6Lkl7JB May 24th 2022, 8:05pm |
|
@InsiderAlerts4U $AGIO: New Insider Filing on AGIOS PHARMACEUTICALS, INC.'s Director KAYE I FOSTER-CHEEK: https://t.co/V7aAQ2yY4s May 24th 2022, 8:05pm |
 |
@FlashAlert_me $AGIO [15s. delayed] filed SEC form 4: Director Scadden David: Converted securities 1,585 of Common stock at price… https://t.co/mXhYyZmvOz May 24th 2022, 8:05pm |
|
@FlashAlert_me $AGIO [15s. delayed] filed SEC form 4: Director CLARK IAN T: Converted securities 1,585 of Common stock at price $… https://t.co/FF5nh8dcWJ May 24th 2022, 8:05pm |
|
@FlashAlert_me $AGIO [15s. delayed] filed SEC form 4: Director Clancy Paul J: Converted securities 1,585 of Common stock at price… https://t.co/cXFxn0NGvn May 24th 2022, 8:05pm |
 |
@bot_chatty RT @FlashAlert_me: $AGIO [15s. delayed] filed SEC form 4: Director Schenkein David P: Converted securities 1,585 of Common stock at price… May 24th 2022, 8:05pm |
|
@FlashAlert_me $AGIO [15s. delayed] filed SEC form 4: Director Schenkein David P: Converted securities 1,585 of Common stock at p… https://t.co/PUr8D6yhFg May 24th 2022, 8:05pm |
|
@FlashAlert_me $AGIO [15s. delayed] filed SEC form 4: Director Ho Maykin: Converted securities 1,585 of Common stock at price $0… https://t.co/ZoR5l73FnN May 24th 2022, 8:05pm |
|
@FlashAlert_me $AGIO [15s. delayed] filed SEC form 4: Director MARAGANORE JOHN: Converted securities 1,585 of Common stock at pri… https://t.co/50gOSUNMVC May 24th 2022, 8:05pm |
 |
@OwenMar54200817 $AGIO Top Analyst price target today https://t.co/2izrP1g81o May 23rd 2022, 6:05pm |
|
@Tickeron $AGIO in Downtrend: Stochastic indicator stays in oversold zone for 1 day. View odds for this and other indicators:… https://t.co/knQUtm4xzJ May 23rd 2022, 2:05pm |
 |
@MSollender @Biohazard3737 @bio_clouseau $KURA was paused for the same reason in Nov 21 (lifted in Jan 22) $AGIO IDH stuff had… https://t.co/xVAYNr7M0U May 19th 2022, 8:05pm |
 |
@dkjhaunc RT @JohnCendpts: Once again shaking things up $AGIO Agios CSO to depart amid layoffs as biotech looks for new drugs to license or acquire… May 19th 2022, 6:05pm |
|
@Tickeron $AGIO in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators:… https://t.co/Eua1po3Ejy May 19th 2022, 2:05pm |
|
@mediasentiment $AGIO new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 16 May 19th 2022, 7:05am |
 |
@BotLedge $AGIO - On May 15, 2022, Bruce Car, Ph.D. notified Agios Pharmaceuticals, Inc. (the “Company”) of his decision to r… https://t.co/dGhsBer03t May 18th 2022, 8:05pm |
 |
@investor_feed $AGIO 8-K Agios Pharmaceuticals (18 May, 4:02pm) ? Departure of Directors or Certain Officers; Election of Dir… https://t.co/KQAgmfhd5N May 18th 2022, 8:05pm |
|
@FlashAlert_me $AGIO [15s. delayed] filed form 8-K on May 18, 16:02:01 https://t.co/c7M8SdU8m2 May 18th 2022, 8:05pm |
 |
@TradeWithAlerts Nice print for $AGIO Size: 152530 Price: 21.15 Amount: $3,226,009.50 Time: 1600 See more: https://t.co/Xjji0dbYtI J… https://t.co/jawLdQyyU0 May 18th 2022, 8:05pm |
|
@Tickeron $AGIO in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators:… https://t.co/hi6epJ5mMH May 18th 2022, 2:05pm |
 |
@MarcJacksonLA $AGIO Leerink Sets Agios Pharmaceuticals PT At $33, Market Perform Rating https://t.co/xKruSlBFiq May 17th 2022, 11:05pm |
|
@MarcJacksonLA $AGIO After 14 years, Agios is looking for a partner to tango with, but tough changes lie ahead https://t.co/bfFImLZ7LM May 17th 2022, 10:05pm |
 |
@LlcBillionaire Agios Is Looking For Development Partner, Lays Off Exploratory Research Staff https://t.co/6OWOaoXzmR $AGIO May 17th 2022, 4:05pm |
 |
@newsfilterio Agios Is Looking For Development Partner, Lays Off Exploratory Research Staff $AGIO https://t.co/W8xnUSOtiU May 17th 2022, 4:05pm |
 |
@FierceBiotech Scholar Rock, Agios Pharmaceuticals join Fierce Biotech's Layoff Tracker $SRRK $AGIO https://t.co/8KOGiZYjoG May 17th 2022, 2:05pm |
 |
@JoshuaT68082144 $AGIO ?Top analyst price target today? https://t.co/0keX25S3AK May 17th 2022, 1:05pm |
 |
@Gambiste1 RT @thudderwicks: $AGIO The initiative is expected to deliver annual average cost savings of $40-50M associated with research and related e… May 17th 2022, 12:05pm |
 |
@thudderwicks $AGIO The initiative is expected to deliver annual average cost savings of $40-50M associated with research and rel… https://t.co/J2F5dtw9Sn May 17th 2022, 12:05pm |
|
@thudderwicks $AGIO to cut 50 jobs, Chief Scientific Officer to step down https://t.co/rrY2Ytqs7b May 17th 2022, 12:05pm |
 |
@vtmtrading Agios Pharmaceuticals to cut 50 jobs, Chief Scientific Officer to step down $AGIO May 17th 2022, 12:05pm |
 |
@MarketCurrents $AGIO - Agios chief scientific officer to depart amid layoffs as company pivots to genetic diseases https://t.co/AIHWzqSo8x May 17th 2022, 11:05am |
 |
@PSBROOKES News of big cuts in basic R&D from @AgiosPharma $AGIO this morning??. What does it mean for basic drug research in… https://t.co/rTqRmrL0I9 May 17th 2022, 11:05am |
 |
@bthefirsttoknow First out// $AGIO: SVB Leerink Maintains Market Perform on Agios Pharmaceuticals, Raises Price Target to $33 https://t.co/gGGJe2RSur May 17th 2022, 10:05am |
 |
@BioIDEA_NYC Cambridge biotech Agios to cut more than 10 percent of its workforce $AGIO https://t.co/v8MNgGbivN May 17th 2022, 1:05am |
|
@newsfilterio Agios Announces Evolution of Research Organization $AGIO https://t.co/2mRqApl52p May 17th 2022, 1:05am |
 |
@Briefingcom $AGIO: Agios Pharma announces evolution of its research organization; to reduce up to 50 research roles https://t.co/BlgNg4lA9n May 16th 2022, 10:05pm |
 |
@Biotenic @bigpharmaguy if this is what evolving looks like then $agio is on the road to extinction May 16th 2022, 10:05pm |
 |
@ScripMandy $AGIO R&D leadership change-up announced and up to 50 people will lose jobs as the company shifts away from early r… https://t.co/iFyNra1NYu May 16th 2022, 9:05pm |
 |
@PearlF @bradloncar On the Zoom call with $AGIO employees, Pearl Jam's "Do the Evolution" was playing https://t.co/DIeBl6TjiB May 16th 2022, 9:05pm |
 |
@precisionmedbot RT @RLCscienceboss: Cambridge rare disease #biotech firm @AgiosPharma $AGIO said that it would lay off up to 50 people working in its early… May 16th 2022, 9:05pm |
 |
@RLCscienceboss Cambridge rare disease #biotech firm @AgiosPharma $AGIO said that it would lay off up to 50 people working in its e… https://t.co/uaTeeq1leh May 16th 2022, 9:05pm |
|
@mediasentiment $AGIO new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 538 May 16th 2022, 8:05pm |
|
@MarcJacksonLA $AGIO Agios to cut jobs as it moves away from exploratory research https://t.co/739zLjHBXb via @BioPharmaDive May 16th 2022, 8:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.